` INCR (InterCure Ltd) vs Tel Aviv 355 Comparison - Alpha Spread

I
INCR
vs
T
Tel Aviv 355

Over the past 12 months, INCR has underperformed Tel Aviv 355, delivering a return of -25% compared to the Tel Aviv 355's +53% growth.

Stocks Performance
INCR vs Tel Aviv 355

Loading
INCR
Tel Aviv 355
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
INCR vs Tel Aviv 355

Performance Gap Between INCR and TA35
HIDDEN
Show

Performance By Year
INCR vs Tel Aviv 355

Loading
INCR
Tel Aviv 355
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
InterCure Ltd vs Peers

Tel Aviv 355
INCR
LLY
JNJ
ROG
AZN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

InterCure Ltd
Glance View

Market Cap
226.5m ILS
Industry
Pharmaceuticals

InterCure Ltd. engages in the business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

INCR Intrinsic Value
HIDDEN
Show
Back to Top